Live feed08:00:00·557dPRReleasevia QuantisnowD. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public OfferingByQuantisnow·Wall Street's wire, on your screen.IBRX· ImmunityBio Inc.Health Care
